CLINICAL_TRIALS
trial_result
· 2009-12-30
Clinical Trial Update: Efficacy and Safety of Ciclesonide (CIC) Administered Twice Daily in Pediatric Patients With Asthma. [Phase 3]
Summary
Phase 3 trial evaluating twice-daily ciclesonide in pediatric asthma showed efficacy and safety; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2009-12-30